Sirolimus for systemic lupus erythematosus

Lancet. 2018 Sep 1;392(10149):733-734. doi: 10.1016/S0140-6736(18)31792-6.

Authors

Hannah Q Hu¹, Frederick J Lee², Roger Garsia²

Affiliations

¹ Department of Clinical Immunology and Allergy, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia. Electronic address: hannah.hu@health.nsw.gov.au.
² Department of Clinical Immunology and Allergy, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.

PMID: 30191825
DOI: 10.1016/S0140-6736(18)31792-6

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Lupus Erythematosus, Systemic*
Sirolimus*

Substances

Sirolimus